Immunological aspects of resistance to the oncogenic effect of 3-methylcholanthrene in mice.
D000373:Agglutinins / Q000032:analysis; D000818:Animals; D000917:Antibody Formation; D002004:Brucella Vaccine / Q000008:administration & dosage; D004912:Erythrocytes / Q000276:immunology; D005260:Female; D006084:Graft Rejection; D006460:Hemolysin Proteins / Q000032:analysis; D006462:Hemolytic Plaque Technique; D006824:Hybridization, Genetic; D007114:Immunization; D007166:Immunosuppressive Agents; D007274:Injections, Intraperitoneal; D007279:Injections, Subcutaneous; D008297:Male; D008748:Methylcholanthrene / Q000008:administration & dosage; D051379:Mice; D008815:Mice, Inbred Strains; D012513:Sarcoma, Experimental / Q000139:chemically induced / Q000276:immunology*; D012756:Sheep / Q000276:immunology; D016038:Skin Transplantation; D014184:Transplantation, Homologous
D000373:Agglutinins; D002004:Brucella Vaccine; D006460:Hemolysin Proteins; D007166:Immunosuppressive Agents; D008748:Methylcholanthrene